Posts by: Isaura Santos

Isaura Santos

Isaura Santos graduated with a BS in Cell and Molecular Biology from Universidade Nova de Lisboa and a MA in Communication, Culture and Information Technologies from University Institute of Lisbon (ISCTE-IUL). Her professional interests include science communication, public awareness of science and communication of science through entertainment.

March 11, 2015March 11, 2015

Zykadia by Novartis Recommended For EU Approval To Treat ALK+ NSCLC Patients Previously Treated With Crizotinib

Lung Cancer, News

Zykadia from Novartis was recommended for EU approval to address treatment for adult patients suffering from anapestic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC), also known as ALK+NSCLC, which has been treated previously with crizotinib. If ... Read more

March 11, 2015November 6, 2015

Corbus Pharmaceuticals’ IND Receives Clearance From FDA To Start Phase 2 Trials For Scleroderma

News, Scleroderma

Corbus Pharmaceuticals recently announced that the company’s Investigational New Drug (IND) application to the United States Food and Drug Administration (FDA) is now open and has received clearance to initiate a Phase 2 clinical ... Read more

March 10, 2015March 10, 2015

Targeted Lung Cancer Therapies Are Replacing Conventional Treatments

Lung Cancer, News

As the market for lung cancer therapeutics continues to grow, drug manufacturers are competing to find their own niches. Approximately 130 drugs to address small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC) are currently ... Read more

March 6, 2015November 6, 2015

Thomson Reuters Launches Asthma Research Partnership Program

Asthma, News

The Intellectual Property & Science division of Thomson Reuters recently announced the launch of MetaMiner™ Asthma, a disease-focused collaboration committed to advancing research on several pathological pathways that may be the cause of asthma, and the advancement of new methods to ... Read more

March 5, 2015November 9, 2015

Sunovion Launches Phase 3 Clinical Trial For First Nebulizer-Delivered LAMA for COPD

COPD, News

Sunovion Pharmaceuticals Inc. recently announced the beginning of enrollment for its Phase 3 clinical trial plan for SUN-101 (glycopyrrolate) solution for inhalation to be delivered through the investigational eFlow®nebulizer system (SUN-101/eFlow®) from PARI Pharma GmbH. ... Read more

March 4, 2015November 5, 2015

New Grant Will Fund Research at Dayton Children’s Cystic Fibrosis Center

Cystic Fibrosis, News

A new grant will support research at the Dayton Children’s Hospital Cystic Fibrosis Center as part of the largest cystic fibrosis (CF) clinical trial in the world. Nicholas Thomas of Dayton spends ... Read more

March 4, 2015November 9, 2015

Adamis Pharma Announces Optimistic Results for Beclomethasone Dipropionate HFA Product for Asthma and COPD

COPD, News

Adamis Pharmaceuticals Corporation recently announced promising outcomes from the pharmacokinetic assessment of its beclomethasone dipropionate HFA product APC-1000 for asthma and COPD. This study was a Phase I, randomized, open label, single-dose, four-way crossover pharmacokinetic evaluation comparing the company’s APC-1000 (Beclomethasone Dipropionate HFA, ... Read more

March 2, 2015March 2, 2015

Ancon Medical Creates Lung Cancer Breath Test

Lung Cancer, News

American medical device maker Ancon Medical Inc., recently developed an innovative new breath screening technology that allows clinicians to easily detect biomarkers for dangerous and deadly diseases at their earliest stages. The Nanoparticle Biomarker Tagging ... Read more

February 25, 2015November 9, 2015

Shisha Smoking Not Much Safer than Cigarette Smoking Due to Heavy Metals

COPD, News

In disagreement with what is commonly believed, only a small part of heavy metals are actually eliminated in the supposed filtration process of smoking shisha, known also as hookah, explained a research study titled “Compartmental Analysis of Metals ... Read more

February 25, 2015February 25, 2015

Lung Cancer Diagnosis Breath Test Being Tested In Clinical Trial

Lung Cancer

A clinical trial conducted by respiratory experts from the University of Leicester is supporting the development of a potentially innovative ‘breath test’ that will be able to diagnose lung cancer. The LuCID (Lung Cancer Indicator Detection) programme ... Read more